Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2002
08/29/2002WO2002066630A1 Methods of modifying eukaryotic cells
08/29/2002WO2002066626A2 Regulation of human mut/nudix nucleoside triphosphate pyrophosphohydrolase
08/29/2002WO2002066618A1 Rapid production of monoclonal antibodies
08/29/2002WO2002066617A1 Method for detecting a risk of hypertension and uses thereof
08/29/2002WO2002066507A2 Histidine phosphatase interacting protein of 120 kd
08/29/2002WO2002066504A2 Protein-protein interactions in saccharomyces cerevisiae
08/29/2002WO2002066494A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
08/29/2002WO2002066028A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
08/29/2002WO2002065943A2 Ocular tear growth factor-like protein
08/29/2002WO2002065889A1 Method for examining cell and tissue samples
08/29/2002WO2002052034A8 Bioscopy method and method of nucleic acid amplification
08/29/2002WO2002048676A3 Multiple array system for integrating bioarrays
08/29/2002WO2002042316A3 Pna analogues
08/29/2002WO2002041836A3 Antisense modulation of src-1 expression
08/29/2002WO2002038032A3 Methods and devices for collecting and processing mammary fluid
08/29/2002WO2002037209A3 System, method, and computer software product for linked window interfaces
08/29/2002WO2002036624A3 Methods, compositions and therapeutic applications relating to fortilin (= translationally controlled tumor protein, tctp) and modulators thereof
08/29/2002WO2002033112A3 Protein-protein interactions in neurodegenerative diseases
08/29/2002WO2002030950A3 Haplotypes of the fy gene
08/29/2002WO2002030949A3 Haplotypes of the ltb4r gene
08/29/2002WO2002029006A3 Methods for parallel measurement of genetic variations
08/29/2002WO2002022795A3 Isolated human kinase proteins, nucleic acid molecules and uses thereof
08/29/2002WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo
08/29/2002WO2002018622A3 TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b)
08/29/2002WO2002016426A3 Coaster, a human coactivator of steroid receptors
08/29/2002WO2002014857A3 Direct selection of protein complexes relevant to the physiological or diagnostic context of a biological specimen
08/29/2002WO2002010403A3 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
08/29/2002WO2002010388A3 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
08/29/2002WO2002008241A3 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
08/29/2002WO2002006788A3 Electrochemical method for measuring chemical reaction rates
08/29/2002WO2001096547A3 Human kinases
08/29/2002WO2001090758A3 Diagnosis of alzheimer's disease ldl receptor protein-1
08/29/2002WO2001085952A3 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
08/29/2002WO2001083828A9 TGFβ-RII PROMOTER POLYMORPHISMS
08/29/2002WO2001083751A3 Methods for binding an exogenous molecule to cellular chromatin
08/29/2002WO2001082975A3 Membrane-permeant peptide complexes for medical imaging
08/29/2002WO2001079284A3 Therapeutic compounds and methods for formulating v3, a versican isoform
08/29/2002WO2001077338A3 Human protein kinases and protein kinase-like enzymes
08/29/2002WO2001071342A3 Identification of mast cell/basophil activation inhibitors
08/29/2002WO2001068858A3 Human g protein-coupled receptors
08/29/2002WO2001068848A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/29/2002WO2001064903A3 Novel human transferase proteins and polynucleotides encoding the same
08/29/2002WO2001062975A3 Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination
08/29/2002WO2001062962A3 Component for interaction analysis comprising probe molecule species which create co-operation effects
08/29/2002WO2001062960A3 Method for detecting cytosine methylation in dna samples
08/29/2002WO2001061055A3 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
08/29/2002WO2001061030A3 LIBRARIES OF OPTIMUM SUBSEQUENCE REGIONS OF mRNA AND GENOMIC DNA FOR CONTROL OF GENE EXPRESSION
08/29/2002WO2001060408A3 Microcompetiton and human disease
08/29/2002WO2001042504A3 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum
08/29/2002WO2001042462A9 Phospholipase a2 inhibitory peptides from python reticulatus
08/29/2002WO2001027328A8 Particle analysis assay for biomolecular quantification
08/29/2002WO2001020019A9 Implantable glucose sensor
08/29/2002WO2001012862A9 Compositions and methods for preparing oligonucleotide solutions
08/29/2002WO2001011359A9 Color space analysis in biochemical and immunological assays
08/29/2002WO2001007481A9 Antitumor antibodies, proteins, and uses thereof
08/29/2002WO2001004629A9 E4orf4 and pp2a polypeptides, modulators, and mimetics for selectively inducing cell death
08/29/2002WO2000066709A9 Zymogen activation system
08/29/2002WO2000061720A9 Allele-specific strand displacement amplification primers and method
08/29/2002WO2000061606A9 Novel human voltage-gated potassium channel
08/29/2002WO2000060120A9 Methods of detecting microorganism using immobilized probes
08/29/2002WO2000056866A9 Akt-3 nucleic acids, polypeptides, and uses thereof
08/29/2002WO2000034474A9 Growth factor homolog zvegf3
08/29/2002WO2000034447A9 Human ubiquitin ligase e3 for the modulation of nf-kappa b
08/29/2002WO2000031306A9 Multiplex amplification of short tandem repeat loci
08/29/2002WO2000023569A9 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
08/29/2002WO2000022115A9 Assays for identifying functional alterations in the p53 tumor suppressor
08/29/2002WO2000011218A9 Expression monitoring for human cytomegalovirus (hcmv) infection
08/29/2002WO1999057280A9 Neisseria meningitidis antigens and compositions
08/29/2002US20020120964 Relates to a glyphosate tolerant cotton plant PV- GHGT07(1445) and to assays for detecting its presence; detection methods of Roundup Ready registered cotton and progeny; DNA from the cotton cell flanking the insertion site and is diagnostic
08/29/2002US20020120952 Liquid reagent for calcium assay
08/29/2002US20020120947 Protein-protein interactions in neurodegenerative disorders
08/29/2002US20020120526 Novel amplicon in the 20q13 region of human chromosome 20 and uses thereof
08/29/2002US20020120409 Methods for gene expression analysis
08/29/2002US20020120408 System and method for tracking and controlling infections
08/29/2002US20020120406 Diagnostic method and apparatus
08/29/2002US20020120151 Composition and device for detecting leukocytes in urine
08/29/2002US20020120127 Replica amplification of nucleic acid arrays
08/29/2002US20020120126 Making and using immobilized arrays of nucleic acids; improve the efficiency of multiplex polymerase chain reaction (PCR) using arrays of immobilized nucleic acids
08/29/2002US20020120123 Human vascular endothelial growth factor 2
08/29/2002US20020120121 Antisense therapy of cancer; Inhibitors of Apoptosis Proteins (IAPs) and an additional related antiapoptotic protein, NAIP;
08/29/2002US20020120117 Polynucleotide that exhibits urothelial cell-specific transcriptional response element (TRE) activity; adenoviral vectors which replicate preferentially in urothelial cells; treating bladder cancer for example
08/29/2002US20020120103 17 human secreted proteins
08/29/2002US20020120100 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents
08/29/2002US20020120008 Life extension of drosophila by a drug treatment
08/29/2002US20020120004 Determining the level of expression in cancer cells of a marker and identifying that an agent can be used as anticancer agent when the marker is expressed at a certain level
08/29/2002US20020119927 Protein-protein interactions in neurodegenerative diseases
08/29/2002US20020119925 Serine proteases
08/29/2002US20020119565 Isolation and use of solid tumor stem cells
08/29/2002US20020119562 Method for selecting improved vectors
08/29/2002US20020119548 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
08/29/2002US20020119547 58569 and 50111, human proteins and methods of use thereof
08/29/2002US20020119543 Method for determining eye disorders by determining mutations in 11-cis retinol dehydrogenase
08/29/2002US20020119542 Nucleic acid molecules encoding red and green emitting luciferases
08/29/2002US20020119534 Stabilized aqueous nucleoside triphosphate solutions
08/29/2002US20020119533 Oligonucleotide anchor and primer, anchor having nucleic acid chemistry which is not substrate for reverse transcriptases and DNA polymerases, and 3'-end not capable of priming DNA synthesis, primer has chemistry which is substrate
08/29/2002US20020119526 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
08/29/2002US20020119524 Novel molecules of the T129-related protein family and uses thereof
08/29/2002US20020119520 Polypeptide for use in the screening of bactericides and preventing infections
08/29/2002US20020119519 Nucleotide sequences coding preferential polyeptide for use in the treatment of cancer, kidney and respiratory disorders
08/29/2002US20020119518 Peptide for use in treatment and diagnosis of heart defects
1 ... 2251 2252 2253 2254 2255 2256 2257 2258 2259 2260 2261 2262 2263 2264 2265 2266 2267 2268 2269 2270 2271 ... 3003